Annual Current Liabilities
$651.30 M
-$577.60 M-47.00%
31 December 2023
Summary:
Emergent BioSolutions annual total current liabilities is currently $651.30 million, with the most recent change of -$577.60 million (-47.00%) on 31 December 2023. During the last 3 years, it has risen by +$266.80 million (+69.39%). EBS annual current liabilities is now -47.00% below its all-time high of $1.23 billion, reached on 31 December 2022.EBS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$229.90 M
-$389.80 M-62.90%
30 September 2024
Summary:
Emergent BioSolutions quarterly total current liabilities is currently $229.90 million, with the most recent change of -$389.80 million (-62.90%) on 30 September 2024. Over the past year, it has dropped by -$434.10 million (-65.38%). EBS quarterly current liabilities is now -81.29% below its all-time high of $1.23 billion, reached on 31 December 2022.EBS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.0% | -65.4% |
| 3 y3 years | +69.4% | -37.1% |
| 5 y5 years | +225.0% | -16.5% |
EBS Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -47.0% | +74.1% | -81.3% | at low |
| 5 y | 5 years | -47.0% | +225.0% | -81.3% | +11.0% |
| alltime | all time | -47.0% | +2064.3% | -81.3% | +664.0% |
Emergent BioSolutions Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $229.90 M(-62.9%) |
| June 2024 | - | $619.70 M(-1.7%) |
| Mar 2024 | - | $630.20 M(-3.2%) |
| Dec 2023 | $651.30 M(-47.0%) | $651.30 M(-1.9%) |
| Sept 2023 | - | $664.00 M(-4.2%) |
| June 2023 | - | $693.20 M(-43.0%) |
| Mar 2023 | - | $1.22 B(-1.1%) |
| Dec 2022 | $1.23 B(+228.6%) | $1.23 B(+357.9%) |
| Sept 2022 | - | $268.40 M(-3.0%) |
| June 2022 | - | $276.70 M(+11.0%) |
| Mar 2022 | - | $249.20 M(-33.4%) |
| Dec 2021 | $374.00 M(-2.7%) | $374.00 M(+2.4%) |
| Sept 2021 | - | $365.40 M(-3.3%) |
| June 2021 | - | $377.80 M(+2.1%) |
| Mar 2021 | - | $370.20 M(-3.7%) |
| Dec 2020 | $384.50 M(+77.8%) | $384.50 M(+28.5%) |
| Sept 2020 | - | $299.30 M(+1.9%) |
| June 2020 | - | $293.70 M(+41.8%) |
| Mar 2020 | - | $207.10 M(-4.3%) |
| Dec 2019 | $216.30 M(+7.9%) | $216.30 M(-21.4%) |
| Sept 2019 | - | $275.30 M(-8.6%) |
| June 2019 | - | $301.20 M(+21.3%) |
| Mar 2019 | - | $248.40 M(+24.0%) |
| Dec 2018 | $200.40 M(+100.2%) | $200.40 M(+96.4%) |
| Sept 2018 | - | $102.01 M(+5.4%) |
| June 2018 | - | $96.81 M(+11.4%) |
| Mar 2018 | - | $86.87 M(-13.2%) |
| Dec 2017 | $100.10 M(-5.4%) | $100.10 M(+32.7%) |
| Sept 2017 | - | $75.43 M(+3.4%) |
| June 2017 | - | $72.93 M(+7.7%) |
| Mar 2017 | - | $67.71 M(-36.0%) |
| Dec 2016 | $105.86 M(+6.3%) | $105.86 M(-4.0%) |
| Sept 2016 | - | $110.31 M(+6.2%) |
| June 2016 | - | $103.86 M(+14.8%) |
| Mar 2016 | - | $90.45 M(-9.2%) |
| Dec 2015 | $99.61 M | $99.61 M(+12.3%) |
| Sept 2015 | - | $88.72 M(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $86.96 M(+8.3%) |
| Mar 2015 | - | $80.30 M(-13.6%) |
| Dec 2014 | $92.94 M(+64.1%) | $92.94 M(+14.1%) |
| Sept 2014 | - | $81.42 M(+6.5%) |
| June 2014 | - | $76.43 M(+5.7%) |
| Mar 2014 | - | $72.32 M(+27.7%) |
| Dec 2013 | $56.65 M(-8.5%) | $56.65 M(+0.0%) |
| Sept 2013 | - | $56.63 M(+16.1%) |
| June 2013 | - | $48.78 M(+12.0%) |
| Mar 2013 | - | $43.54 M(-29.7%) |
| Dec 2012 | $61.91 M(-12.9%) | $61.91 M(+22.4%) |
| Sept 2012 | - | $50.57 M(+13.7%) |
| June 2012 | - | $44.47 M(+3.4%) |
| Mar 2012 | - | $42.99 M(-39.5%) |
| Dec 2011 | $71.05 M(-6.2%) | $71.05 M(+3.1%) |
| Sept 2011 | - | $68.93 M(-4.9%) |
| June 2011 | - | $72.50 M(+2.2%) |
| Mar 2011 | - | $70.93 M(-6.3%) |
| Dec 2010 | $75.72 M(+38.4%) | $75.72 M(+51.9%) |
| Sept 2010 | - | $49.86 M(+9.7%) |
| June 2010 | - | $45.44 M(-5.6%) |
| Mar 2010 | - | $48.12 M(-12.0%) |
| Dec 2009 | $54.70 M(+1.3%) | $54.70 M(-4.5%) |
| Sept 2009 | - | $57.31 M(-21.4%) |
| June 2009 | - | $72.91 M(+34.5%) |
| Mar 2009 | - | $54.21 M(+0.3%) |
| Dec 2008 | $54.02 M(-2.9%) | $54.02 M(+4.8%) |
| Sept 2008 | - | $51.57 M(-1.5%) |
| June 2008 | - | $52.37 M(+6.1%) |
| Mar 2008 | - | $49.38 M(-11.3%) |
| Dec 2007 | $55.66 M(-13.5%) | $55.66 M(+56.7%) |
| Sept 2007 | - | $35.51 M(+10.1%) |
| June 2007 | - | $32.26 M(+5.9%) |
| Mar 2007 | - | $30.46 M(-52.7%) |
| Dec 2006 | $64.35 M(+113.8%) | $64.35 M(+67.3%) |
| Sept 2006 | - | $38.47 M(+27.8%) |
| Dec 2005 | $30.09 M(-12.0%) | $30.09 M(-12.0%) |
| Dec 2004 | $34.19 M | $34.19 M |
FAQ
- What is Emergent BioSolutions annual total current liabilities?
- What is the all time high annual current liabilities for Emergent BioSolutions?
- What is Emergent BioSolutions annual current liabilities year-on-year change?
- What is Emergent BioSolutions quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly current liabilities year-on-year change?
What is Emergent BioSolutions annual total current liabilities?
The current annual current liabilities of EBS is $651.30 M
What is the all time high annual current liabilities for Emergent BioSolutions?
Emergent BioSolutions all-time high annual total current liabilities is $1.23 B
What is Emergent BioSolutions annual current liabilities year-on-year change?
Over the past year, EBS annual total current liabilities has changed by -$577.60 M (-47.00%)
What is Emergent BioSolutions quarterly total current liabilities?
The current quarterly current liabilities of EBS is $229.90 M
What is the all time high quarterly current liabilities for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly total current liabilities is $1.23 B
What is Emergent BioSolutions quarterly current liabilities year-on-year change?
Over the past year, EBS quarterly total current liabilities has changed by -$434.10 M (-65.38%)